Show Summary Details
Page of

Obesity co-morbidities 

Obesity co-morbidities
Obesity co-morbidities

Mark Bellamy

and Michel Struys

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 29 November 2020

Not all obese patients suffer from co-morbidity.

In many cases, the presence of obesity-related co-morbidity is the reason a patient presents for surgery.

The majority of people with type 2 diabetes are overweight.

The waist circumference, rather than BMI, is the best predictor of type 2 diabetes.

Insulin therapy can be problematic in the morbidly obese.

There is a relationship between diet in the days prior to surgery and the degree of liver fatty infiltration at laparotomy.

In morbid obesity, moderate hypertension is present in 50% and severe hypertension in 10%.

There is a 14% additional chance of a cardiac event at 9-year follow-up for each BMI unit.

There is a BMI-related increase in the prevalence and severity of asthma.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.